AstraZeneca Boosts Pipeline with $232 Million Synairgen Deal – Analyst Blog
AstraZeneca ( AZN ) announced that it has entered into an agreement with UK based Synairgen to in license its …read more
Orexigen Slumps as Obesity Drug Approval Delayed – Analyst Blog
Orexigen Therapeutics, Inc. ‘s ( OREX ) shares were down 14.68% after the company announced that the FDA has delayed …read more
Genomic Health’s Oncotype DX Redefines Breast Cancer Therapy – Analyst Blog
Genomic Health, Inc. ( GHDX ) reported positive results from an initial validation study of Oncotype DX in patients suffering …read more
Groupon Freebies Now on Apple’s iOS-based Devices – Analyst Blog
Groupon ( GRPN ) recently launched Freebies on Apple ‘s ( AAPL ) iOS based devices. Launched in 2013, These …read more
Barrett Business Services Down to Strong Sell, Shares Fall – Analyst Blog
Zacks Investment Research downgraded Barrett Business Services Inc. ( BBSI ) to a Zacks Rank #5 (Strong Sell) on Jun …read more
Amgen-AstraZeneca Psoriatic Arthritis Drug Shows Improvement – Analyst Blog
AstraZeneca ( AZN ) and partner Amgen ( AMGN ) announced that data from a phase II study (n = …read more
The Only Tool You Need To Find The Best Values In Tech
“GARP” short for “growth at a reasonable price” is an investing style you’ll hear …read more
Talisman Energy May Sell a Stake in Duvernay Gas Resources – Analyst Blog
As per media reports, Canadian energy explorer, Talisman Energy Inc. ( TLM ) is now in an initial stage of …read more
Motorola Solutions’ MC18 Takes Shopping to a New Level – Analyst Blog
In order to enhance the shopping experience for customers, Motorola Solutions Inc. ( MSI ) has launched its fifth generation …read more
JetBlue Airways Slips Despite Strong May Traffic – Analyst Blog
Leading passenger airline JetBlue Airways Corporation ( JBLU ) slipped 1.88% on Wednesday trade on Nasdaq despite registering strong traffic …read more